ES2177666T3 - Remedio para la endotoxinemia y disfunciones de organos multiples inducidos por la misma. - Google Patents

Remedio para la endotoxinemia y disfunciones de organos multiples inducidos por la misma.

Info

Publication number
ES2177666T3
ES2177666T3 ES95939419T ES95939419T ES2177666T3 ES 2177666 T3 ES2177666 T3 ES 2177666T3 ES 95939419 T ES95939419 T ES 95939419T ES 95939419 T ES95939419 T ES 95939419T ES 2177666 T3 ES2177666 T3 ES 2177666T3
Authority
ES
Spain
Prior art keywords
endotoxinemia
remedy
induited
dysfunctions
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95939419T
Other languages
English (en)
Inventor
Michio Ohta
Takaaki Hasegawa
Masayuki Nadai
Yasuko Yoshida
Mitsuo Kawase
Tadahiko Inukai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NGK Insulators Ltd
Biseiken Co Ltd
Original Assignee
NGK Insulators Ltd
Biseiken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NGK Insulators Ltd, Biseiken Co Ltd filed Critical NGK Insulators Ltd
Application granted granted Critical
Publication of ES2177666T3 publication Critical patent/ES2177666T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

REMEDIO PARA LA ENDOTOXINEMIA Y EL FALLO ORGANICO MULTIPLE DEBIDO A ESTA, QUE CONTIENE ACIDO SIALICO, SU SAL, POLIMERO DE ACIDO SIALICO O SU SAL COMO INGREDIENTE ACTIVO. ES ALTAMENTE EFICAZ ANTE LA MUERTE DEBIDA AL SHOCK Y EL FALLO ORGANICO INDUCIDO POR LAS ENDOTOXINAS Y ES ALTAMENTE SEGURO.
ES95939419T 1995-05-25 1995-12-12 Remedio para la endotoxinemia y disfunciones de organos multiples inducidos por la misma. Expired - Lifetime ES2177666T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12625895 1995-05-25

Publications (1)

Publication Number Publication Date
ES2177666T3 true ES2177666T3 (es) 2002-12-16

Family

ID=14930734

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95939419T Expired - Lifetime ES2177666T3 (es) 1995-05-25 1995-12-12 Remedio para la endotoxinemia y disfunciones de organos multiples inducidos por la misma.

Country Status (8)

Country Link
US (1) US6395717B1 (es)
EP (1) EP0778026B1 (es)
KR (1) KR100198176B1 (es)
CN (1) CN1160078C (es)
CA (1) CA2195863C (es)
DE (1) DE69527205T2 (es)
ES (1) ES2177666T3 (es)
WO (1) WO1996037205A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1093763C (zh) * 1996-02-08 2002-11-06 日本碍子株式会社 抑制癌转移的抗癌剂
JP4005115B1 (ja) * 2007-02-08 2007-11-07 日本臓器製薬株式会社 疼痛疾患治療剤
DK2115010T3 (da) * 2007-02-28 2012-02-06 Lipoxen Technologies Ltd Mindskelse af endotoksin i polysialinsyrer
EP2783691A1 (en) * 2013-03-28 2014-10-01 Rheinische Friedrich-Wilhelms-Universität Bonn Polysialic acid and use for treatment of neurodegenerative and neuroinflammatory diseases
CN105709462B (zh) * 2016-04-28 2016-11-16 南阳师范学院 硬脂酸甘油酯高压水解前的脱气装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393742A (en) 1990-08-30 1995-02-28 Mect Corporation Preparation for treating renal disease
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
AU4835693A (en) * 1993-08-13 1995-03-14 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
US5639734A (en) * 1994-12-20 1997-06-17 Esko; Jeffrey D. Disaccharide inflammation inhibitors and uses thereof

Also Published As

Publication number Publication date
CA2195863C (en) 2001-04-17
CN1160078C (zh) 2004-08-04
EP0778026A1 (en) 1997-06-11
CN1158571A (zh) 1997-09-03
CA2195863A1 (en) 1996-11-28
DE69527205T2 (de) 2003-02-20
DE69527205D1 (de) 2002-08-01
EP0778026B1 (en) 2002-06-26
KR100198176B1 (ko) 1999-06-15
EP0778026A4 (en) 1998-08-12
WO1996037205A1 (fr) 1996-11-28
US6395717B1 (en) 2002-05-28

Similar Documents

Publication Publication Date Title
ES2087916T3 (es) Derivado de pirimidina biciclico, metodo para producir el mismo, y preparacion farmaceutica que contiene el mismo como ingrediente activo.
CL2008002694A1 (es) Combinaciones de principios activos que contienen derivados de acido tetramico sustituido con espirocetal; uso de las combinaciones para combatir plagas animales.
UY25330A1 (es) Nuevos macrólidos
CL2008001768A1 (es) Composicion plaguicida que comprende un compuesto derivado de estrigolactona y un compuesto fungicida; metodo para controlar de modo curativo o preventivo los hongos fitopatogenos de los cultivos; y su uso.
PT835258E (pt) Novos analogos de camptotecina, processos para a sua preparacao, sua utilizacao como farmacos e composicoes farmaceuticas que os contem
ECSP088596A (es) Compuestos de piperazina con accion herbicida
BRPI0519700A2 (pt) misturas fungicidas, agente, processo para combater fungos nocivos fitopatogênicos, semente, uso dos compostos
MX9201564A (es) Derivados de biguanida, metodo para fabricar los mismos, y desinfectantes que contienen los derivados.
PA8577101A1 (es) Nuevos derivados de glicosido de tiofeno, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos
ES2123553T3 (es) Compuestos fluoroalquenilo y su uso como repelentes de plagas.
BRPI0519698A2 (pt) misturas fungicidas, agente, processo para combater fungos nocivos fitopatogênicos, semente, e, uso dos compostos
ES2165523T3 (es) Derivados de la ciclopentano-1,3-diona.
ES2177666T3 (es) Remedio para la endotoxinemia y disfunciones de organos multiples inducidos por la misma.
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
ES2138660T3 (es) Derivados de brasinosteroides y regulador del crecimiento de las plantas que contiene los mismos.
PE56798A1 (es) Mezclas fungicidas
BR0113138A (pt) Composição fungicida, processo de tratamento destinado a combater ou prevenir as doenças fúngicas das culturas e produto
ECSP056033A (es) Compuestos biciclicos y su empleo para combatir hongos nocivos
ECSP066563A (es) Pentafluorosulfanil-benzoilguanidinas, método para su producción, su uso como medicamentos o agentes de diagnóstico, y medicamento que las contiene
BR0317000A (pt) Composições pesticidas
BR0013085A (pt) Compostos espiro heterocìclicos como pesticidas
ES2183158T3 (es) Poli(acidos organicos) y sus analogos para aumentar la eficacia herbicida.
ES2062570T3 (es) L-alfa-glicerofosforil-d-mio-inositol para el tratamiento de neuropatias perifericas y de cerebropatias.
ES2084324T3 (es) Agentes nematicidas.
BR9908098A (pt) Compostos de alcóxi-carbonila substituìdos